Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
The control rate of pancreatic cancer is over 90%! Blockbuster new drug for gastrointestinal tumors won the title of orphan drug by the FDA 21/06/2022 pancreatic cancer CD40 gene
How to improve long-term survival rates in hepatocellular carcinoma? Novel dual immunotherapy shows promising first-line efficacy. 07/06/2022 肝細胞癌 HCC
Can immunotherapy be used for advanced biliary tract cancer? Imfinzi combination therapy significantly improves survival. 06/06/2022 膽道癌 PD-1